Inserm Transfert SA: EU funding, projects and partners

On this page · 5 sections→

01EU funding
02Projects
03Works most with
04Fields
05Is this you?

Where the EU money came from

Funding by EU programme. Amounts are Inserm Transfert SA's own share of each project, not the project's full budget.

FP7 (2007 to 2013)€15.6M · 48 projects
Horizon 2020€10.7M · 33 projects
Horizon Europe€7.9M · 22 projects

Projects

103 EU-funded projects, newest first. Inserm Transfert SA led 2 of them as coordinator. Each links to the official record.

HENIPROTECTPartner
EU-HENIpavirus PROTECTion via inhaled antibody solution
Horizon Europe · 2026–2032 · Project on CORDIS ↗
€177ktheir share
MICRO-NESTPartner
Microbiota–Immune–Cognition Relationships from Neonatal Environments to Social Trajectories
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€208ktheir share
SERENAPartner
Assessing and improving access to health and social care SErvices for children RENdered vulnerable by Abuse
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€398ktheir share
HPV-FASTER-ImplementPartner
Offering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study.
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€355ktheir share
PROACT EU-ResponsePartner
A European Proactive Adaptive Clinical Trials Network within EU-Response
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€516ktheir share
IMPROVE PRETERMPartner
IMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€394ktheir share
EXPOSIGNALZPartner
Dissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€393ktheir share
BE READY PLUSPartner
Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS
Horizon Europe · 2025–2025 · Project on CORDIS ↗
€108ktheir share
INVENTSPartner
Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€411ktheir share
SOLVEPartner
Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€390ktheir share
ARTiDePartner
Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€352ktheir share
MITI 2Partner
Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€468ktheir share
OBELISKPartner
Fighting childhood obesity to stay healthy all over the life
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€513ktheir share
HT-ADVANCEPartner
Improving treatment efficacy in hypertension by biomarker-guided personalised decision support
Horizon Europe · 2023–2029 · Project on CORDIS ↗
€924ktheir share
CARE-IN-HEALTHPartner
CArdiovascularREsolution of INflammation to promote HEALTH
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€152ktheir share
INTERCEPT-T2DPartner
Early Interception of Inflammatory-mediated Type 2 Diabetes
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€400ktheir share
REGeRNAPartner
Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytes
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€399ktheir share
4.UNCAN.euPartner
A Coordination and Support Action to prepare UNCAN.eu platform
Horizon Europe · 2022–2023 · Project on CORDIS ↗
€218ktheir share
MPX-RESPONSEPartner
A clinical research network to improve the management of Monkeypox virus disease
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€395ktheir share
HERVCOVPartner
SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€357ktheir share
BE READYPartner
Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€198ktheir share
ISIDORePartner
Integrated Services for Infectious Disease Outbreak Research
Horizon Europe · 2022–2025 · Project on CORDIS ↗
€192ktheir share
RITA-MI 2Partner
Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial
Horizon 2020 · 2021–2027 · Project on CORDIS ↗
€366ktheir share
CBIG-SCREENPartner
Working collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries
Horizon 2020 · 2021–2026 · Project on CORDIS ↗
€255ktheir share
MAD-CoV 2Partner
Modern approaches for developing antivirals against SARS-CoV 2
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€270ktheir share
EU-RESPONSEPartner
European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€453ktheir share
CAREPartner
Corona Accelerated R&D in Europe
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€450ktheir share
FAIRPartner
FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€248ktheir share
IP-cure-BPartner
Immune profiling to guide host-directed interventions to cure HBV infections
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€300ktheir share
miniNOPartner
Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€391ktheir share
TheraLymphPartner
Gene Therapy to restore lymphatic flow lymphedema
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€215ktheir share
PREMSTEMPartner
Brain injury in the premature born infant: stem cell regeneration research network
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€315ktheir share
HUGODECAPartner
Human Gonad Developmental Cell Atlas
Horizon 2020 · 2020–2022 · Project on CORDIS ↗
€309ktheir share
REMEDIAPartner
Impact of exposome on the course of lung diseases
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€442ktheir share
AB-DiRecTPartner
Antibiotic Distribution and Recovery in Tissue
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€336ktheir share
CARDIATEAMPartner
CARdiomyopathy in type 2 DIAbetes mellitus
Horizon 2020 · 2019–2026 · Project on CORDIS ↗
€310ktheir share
VHFMoDRADPartner
Viral Haemorrhagic Fever: Modern Approaches for developing bedside Rapid Diagnostics
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€245ktheir share
ERINHA-AdvancePartner
Advancing European Research Infrastcuture on Highly Pathogenic Agents
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
€283ktheir share
HERAPartner
Integrating Environment and Health Research: a Vision for the EU
Horizon 2020 · 2019–2022 · Project on CORDIS ↗
€154ktheir share
EJP RDPartner
European Joint Programme on Rare Diseases
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€367ktheir share

Show 40 more projects

OBERONPartner
An integrative strategy of testing systems for identification of EDs related to metabolic disorders
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€380ktheir share
EBRAAssociated partner
European Brain Research Area
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
R-LiNKPartner
Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
€349ktheir share
EU-TRAINPartner
The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
€417ktheir share
CCHFVaccinePartner
Crimean-Congo Haemorrhagic Fever Vaccine
Horizon 2020 · 2017–2025 · Project on CORDIS ↗
€402ktheir share
ZIKAlliancePartner
A global alliance for Zika virus control and prevention
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€363ktheir share
MEDIT-AGEINGPartner
Investigating the impact of meditation training on mental health and wellbeing in the ageing population
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
€152ktheir share
EHVAPartner
European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates
Horizon 2020 · 2016–2023 · Project on CORDIS ↗
€581ktheir share
ERINHA2Partner
European Research Infrastructure on Highly Pathogenic Agents 2
Horizon 2020 · 2016–2017 · Project on CORDIS ↗
€177ktheir share
JPsustaiNDPartner
Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€280ktheir share
MIROCALSPartner
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€421ktheir share
FAIR-PARK-IIPartner
Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€389ktheir share
ENSAT-HTPartner
Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
€408ktheir share
EbolaMoDRADPartner
Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€231ktheir share
EBOVAC2Partner
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
Horizon 2020 · 2014–2021 · Project on CORDIS ↗
€427ktheir share
A-PARADDISEPartner
Anti-Parasitic Drug Discovery in Epigenetics
FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗
€313ktheir share
EXALTPartner
Proposal to assess an innovative Immunotherapy, based on a thioredox peptide antigen, in a Phase I Trial for Type-1 Diabetes
FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗
€240ktheir share
NAREBPartner
Nanotherapeutics for antibiotic resistant emerging bacterial pathogens
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€479ktheir share
BRAINTRAINPartner
Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€410ktheir share
REPAIR-HDPartner
Human pluripotent stem cell differentiation, safety and preparation for therapeutic transplantation in Huntington’s disease
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€475ktheir share
MyasterixCoordinator
Clinical safety, immunogenicity and efficacy of a therapeutic vaccine that combines peptides mimicking antigen receptors on autoimmune B and T cells associated with myasthenia gravis
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€355ktheir share
POC-HCVPartner
Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€220ktheir share
FIBRO-TARGETSPartner
Targeting cardiac fibrosis for heart failure treatment
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€400ktheir share
NANODIODEPartner
Developing Innovative Outreach and Dialogue on responsible nanotechnologies in EU civil society
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€101ktheir share
BIOMARGINPartner
Biomarkers of renal graft injuries in kidney allograft recipients
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€455ktheir share
HOMAGEPartner
Heart OMics in AGEing
FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗
€450ktheir share
NANOATHEROPartner
Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€612ktheir share
AGEDBRAINSYSBIOPartner
SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€343ktheir share
METACARDISPartner
Metagenomics in Cardiometabolic Diseases
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€496ktheir share
DIABIL-2Partner
Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes
FP7 (2007 to 2013) · 2012–2019 · Project on CORDIS ↗
€310ktheir share
HIGHLIGHTPartner
Highlighting EU-funded Health research results via TV media and the internet
FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗
€147ktheir share
ENTENTECoordinator
European Network of Knowledge Transfer in Health
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€641ktheir share
EE-ASIPartner
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€387ktheir share
EUROHYP-1Partner
European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
€143ktheir share
OVER-MYRPartner
Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€177ktheir share
C4LPartner
Chips for Life
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€270ktheir share
InnovaLivPartner
Innovative strategies to generate human hepatocytes for treatment ofmetabolic Liver diseases: Tools for personalized cell therapy
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€365ktheir share
GENEGRAFTPartner
Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector
FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗
€420ktheir share
TINN2Partner
Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€310ktheir share
SCR&TOXPartner
Stem Cells for Relevant Efficient Extended and Normalized Toxicology
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€161ktheir share

Showing the 80 most recent of 103 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

DNA viruses
HIV
RNA viruses
alcohols
alkali metals
allergology
alzheimer
amyotrophic lateral sclerosis
antibiotic resistance
antibiotics
antivirals
anxiety disorders
arteriosclerosis
asthma

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗